Eosinophilia: Difference between revisions
ClaireLewis (talk | contribs) |
Elcatracho (talk | contribs) |
||
| Line 10: | Line 10: | ||
*[[DRESS syndrome]], drug-induced | *[[DRESS syndrome]], drug-induced | ||
*[[Parasitic infection]] | *[[Parasitic infection]] | ||
*[[Coccidioidomycosis]] and other fungal infections | *[[Coccidioidomycosis]] and other [[fungal infections]] | ||
*Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]]) | *Malignancy (e.g. [[lymphoma]], eosinophilic [[leukemia]]) | ||
*Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis) | *Skin disorders (e.g. [[bullous pemphigoid]], dermatitis herpetiformis) | ||
Revision as of 20:02, 8 March 2021
Background
- Defined usually as peripheral eosinophil count >0.5 x 109/L
- Eosinophils normally comprise <7% of total WBC count
Clinical Features
Differential Diagnosis
- Allergic reaction or other hypersensitivity/atopic state
- Urticaria, atopic dermatitis, asthma, drug reaction/hypersensitivity
- DRESS syndrome, drug-induced
- Parasitic infection
- Coccidioidomycosis and other fungal infections
- Malignancy (e.g. lymphoma, eosinophilic leukemia)
- Skin disorders (e.g. bullous pemphigoid, dermatitis herpetiformis)
- Adrenal insufficiency
- Connective tissue disease (e.g. Churg-Strauss syndrome)
- Interstitial nephritis
- Arsenic, gold toxicity